Posted by Michael Wonder on 28 Dec 2020
Lynparza approved in Japan for the treatment of advanced ovarian, prostate and pancreatic cancers
28 December 2020 - Approvals based on the PAOLA-1, PROfound and POLO Phase III trials
AstraZeneca and MSD’s Lynparza (olaparib) has been approved in Japan for the treatment of advanced ovarian, prostate and pancreatic cancers.
